Re-appointment of Mr. Manasvi Manu Thapar as Independent Director of the company for second term of five consecutive financial year subject to the approval of shareholders in the ensuing 15th AGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Longlife Hospital and Research Ltd has announced the re-appointment of Mr. Manasvi Manu Thapar as Independent Director for a second term. The Board of Directors approved this re-appointment on May 30, 2026, based on the recommendation of the Nomination and Remuneration Committee. The new term will commence from September 10, 2026 and continue until September 09, 2031, spanning five consecutive financial years. This re-appointment is subject to approval by shareholders at the upcoming 15th Annual General Meeting. Mr. Thapar has been practicing as a lawyer at Candour Legal firm for 10 years and holds a B.A. L.L.B degree from Nirma University. He is not related to any director of the company and is not debarred from holding the office of director.
This is a routine corporate governance matter confirming continuity of an experienced independent director on the board. The re-appointment signals stability in board composition but is unlikely to have any immediate impact on the stock price as it requires standard shareholder approval.